These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 36661350)

  • 21. Evaluating Upstaging in Ductal Carcinoma In Situ Using Preoperative MRI-Based Radiomics.
    Hong M; Fan S; Yu Z; Gao C; Fang Z; Du L; Wang S; Chen X; Xu M; Zhou C
    J Magn Reson Imaging; 2023 Aug; 58(2):454-463. PubMed ID: 36440711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of combined clinical-radiomics model based on contrast-enhanced MRI in predicting the malignancy of breast non-mass enhancements without an additional diffusion-weighted imaging sequence.
    Li Y; Yang Z; Lv W; Qin Y; Tang C; Yan X; Yin T; Ai T; Xia L
    Quant Imaging Med Surg; 2023 Sep; 13(9):5974-5985. PubMed ID: 37711822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of DCE-MRI, multiparametric MRI and multimodality imaging for discrimination of breast non-mass-like enhancement lesions.
    Zang H; Liu HL; Zhu LY; Wang X; Wei LM; Lou JJ; Zou QG; Wang SQ; Wang SJ; Jiang YN
    Br J Radiol; 2022 Aug; 95(1136):20220211. PubMed ID: 35522775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Breast MRI-based Radiomics for Distinguishing Benign and Malignant Lesions: An Analysis of Sequences and Enhanced Phases.
    Wang G; Guo Q; Shi D; Zhai H; Luo W; Zhang H; Ren Z; Yan G; Ren K
    J Magn Reson Imaging; 2024 Sep; 60(3):1178-1189. PubMed ID: 38006286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Machine Learning-Based Unenhanced Radiomics Approach to Distinguishing Between Benign and Malignant Breast Lesions Using T2-Weighted and Diffusion-Weighted MRI.
    Liu Y; Jia X; Zhao J; Peng Y; Yao X; Hu X; Cui J; Chen H; Chen X; Wu J; Hong N; Wang S; Wang Y
    J Magn Reson Imaging; 2024 Aug; 60(2):600-612. PubMed ID: 37933890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
    Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
    J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.
    Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L
    Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiomic Analysis of Pharmacokinetic Heterogeneity Within Tumor Based on the Unsupervised Decomposition of Dynamic Contrast-Enhanced MRI for Predicting Histological Characteristics of Breast Cancer.
    Zhang L; Fan M; Wang S; Xu M; Li L
    J Magn Reson Imaging; 2022 Jun; 55(6):1636-1647. PubMed ID: 34773446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Using CNN Based on Multiparametric MRI.
    Wang Z; Sun H; Li J; Chen J; Meng F; Li H; Han L; Zhou S; Yu T
    J Magn Reson Imaging; 2022 Sep; 56(3):700-709. PubMed ID: 35108415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of MRI and CT-Based Radiomics and Their Combination for Early Identification of Pathological Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer.
    Li J; Zhang HL; Yin HK; Zhang HK; Wang Y; Xu SN; Ma F; Gao JB; Li HL; Qu JR
    J Magn Reson Imaging; 2023 Sep; 58(3):907-923. PubMed ID: 36527425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy.
    Zhang GM; Han YQ; Wei JW; Qi YF; Gu DS; Lei J; Yan WG; Xiao Y; Xue HD; Feng F; Sun H; Jin ZY; Tian J
    J Magn Reson Imaging; 2020 Oct; 52(4):1239-1248. PubMed ID: 32181985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Machine learning models for differential diagnosing HER2-low breast cancer: A radiomics approach.
    Chen X; Li M; Su D
    Medicine (Baltimore); 2024 Aug; 103(33):e39343. PubMed ID: 39151526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.
    Fan M; Cheng H; Zhang P; Gao X; Zhang J; Shao G; Li L
    J Magn Reson Imaging; 2018 Jul; 48(1):237-247. PubMed ID: 29219225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI-based vector radiomics for predicting breast cancer HER2 status and its changes after neoadjuvant therapy.
    Zhang L; Cui QX; Zhou LQ; Wang XY; Zhang HX; Zhu YM; Sang XQ; Kuai ZX
    Comput Med Imaging Graph; 2024 Dec; 118():102443. PubMed ID: 39427545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple parameters from ultrafast dynamic contrast-enhanced magnetic resonance imaging to discriminate between benign and malignant breast lesions: Comparison with apparent diffusion coefficient.
    Cao Y; Wang X; Shi J; Zeng X; Du L; Li Q; Nickel D; Zhou X; Zhang J
    Diagn Interv Imaging; 2023 Jun; 104(6):275-283. PubMed ID: 36739225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI-Based Breast Cancer Classification and Localization by Multiparametric Feature Extraction and Combination Using Deep Learning.
    Cong C; Li X; Zhang C; Zhang J; Sun K; Liu L; Ambale-Venkatesh B; Chen X; Wang Y
    J Magn Reson Imaging; 2024 Jan; 59(1):148-161. PubMed ID: 37013422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI.
    Liu C; Ding J; Spuhler K; Gao Y; Serrano Sosa M; Moriarty M; Hussain S; He X; Liang C; Huang C
    J Magn Reson Imaging; 2019 Jan; 49(1):131-140. PubMed ID: 30171822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model-Free and Model-based Parameters Derived From CAIPIRINHA-Dixon-TWIST-VIBE DCE-MRI: Associations With Prognostic Factors and Molecular Subtypes of Invasive Ductal Breast Cancer.
    Xie T; Jiang T; Zhao Q; Fu C; Nickel MD; Peng W; Gu Y
    J Magn Reson Imaging; 2023 Jul; 58(1):81-92. PubMed ID: 36433714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of MRI Image Based on Computer Semiautomatic Segmentation Algorithm in the Classification Prediction of Breast Cancer Histology.
    Sheng A; Li A; Xia J; Ye Y
    J Healthc Eng; 2021; 2021():6088322. PubMed ID: 34868525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.